These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 606742)

  • 1. Evaluation of Tc-99m pyridoxal-phenylalanine as a hepatobiliary imaging agent. Part 1. Experimental studies.
    Fotopoulos A; Chiotelis E; Koutoulidis C; Dassiou A; Papadimitriou J
    J Nucl Med; 1977 Dec; 18(12):1189-93. PubMed ID: 606742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Tc-99m pyridoxal-phenylalanine as a hepatobiliary agent. Part 2. Clinical tests.
    Papadimitriou J; Fotopoulos A; Koutoulidis C; Chiotelis E; Tountas C
    J Nucl Med; 1977 Dec; 18(12):1194-8. PubMed ID: 606743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary scintigraphy with a new scanning agent, 99mTc-(SN)-pyridoxylidene-isoleucine.
    Aoki Y; Taniguchi K; Katsumi M
    Am J Gastroenterol; 1979 Dec; 72(6):630-7. PubMed ID: 539581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatobiliary scintigraphy with Tc-99m-EHIDA in patients with obstructive jaundice].
    Hu YZ
    Zhonghua Wai Ke Za Zhi; 1988 Oct; 26(10):631-2, 640. PubMed ID: 3243140
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of 99Tcm-labelled HIDA in hepatobiliary scanning.
    Taylor TV; Sumerling MD; Carter DC; McLoughlin GP; Miller AM
    Br J Surg; 1980 May; 67(5):325-8. PubMed ID: 7388325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of technetium-99m biliary scanning agents based on pyridoxal.
    Baker RJ; Bellen JC
    Int J Nucl Med Biol; 1978; 5(6):279-80. PubMed ID: 738844
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of complete biliary-tract obstruction on serial hepatobiliary imaging in an experimental model: concise communication.
    Klingensmith WC; Whitney WP; Spitzer VM; Klintmalm GB; Koep LM; Kuni CC
    J Nucl Med; 1981 Oct; 22(10):866-8. PubMed ID: 7288484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatobiliary scintigraphy in assessing the state of the choledochus and gallbladder in chronic biliary tract diseases].
    Dumpe EP; Zubovskii GA; Galitskiĭ AB; Savel'ev EA
    Khirurgiia (Mosk); 1981 Oct; (10):25-9. PubMed ID: 7311343
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with 99mTc-disofenin as a cholescintigraphic agent.
    Stadalnik RC; Matolo NM; Jansholt AL; Vera DR
    Radiology; 1981 Sep; 140(3):797-800. PubMed ID: 7025091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
    Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
    J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium-97 hepatobiliary agents for delayed studies of the biliary tract. I. ru-97 PIPIDA: concise communication.
    Schachner ER; Gil MC; Atkins HL; Som P; Srivastava SC; Badia J; Sacker DF; Fairchild RG; Richards P
    J Nucl Med; 1981 Apr; 22(4):352-7. PubMed ID: 7205382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quest for the perfect hepatobiliary radiopharmaceutical.
    Fritzberg AR; Klingensmith WC
    J Nucl Med; 1982 Jun; 23(6):543-6. PubMed ID: 6896213
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT).
    Sugimura K; Nishiyama S; Narabayashi I
    Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432
    [No Abstract]   [Full Text] [Related]  

  • 14. Postoperative evaluation of penetrating hepatic trauma and complications.
    Lecklitner ML; Dittman W
    J Nucl Med; 1984 Sep; 25(9):982-3. PubMed ID: 6540801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerosing cholangitis: cholescintigraphy with Tc-99m-labeled DISIDA.
    Ament AE; Bick RJ; Miraldi FD; Haaga JR; Wiedenmann SD
    Radiology; 1984 Apr; 151(1):197-201. PubMed ID: 6538337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TC-99m(Sn)-N-pyridoxylaminates: a new series of hepatobiliary imaging agents.
    Kato-Azuma M
    J Nucl Med; 1982 Jun; 23(6):517-24. PubMed ID: 7077403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tc-99m-IDA hepatobiliary imaging: a fractured liver.
    Sty JR; Babbitt DP; Squires W
    Clin Nucl Med; 1979 Dec; 4(12):493-4. PubMed ID: 527284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of bilio-intestinal anastomoses using radioisotope cholangiography].
    Gordon F; Muñoz R; Treviño H; Bautista J
    Rev Gastroenterol Mex; 1981; 46(1):7-10. PubMed ID: 6792686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological and functional evaluation criteria of hepatobiliary functional scintigraphy with 99mTc-diethyl-IDA in hepatocellular jaundice].
    Biersack HJ; Breuel HP; Altland H; Bell E
    Nuklearmedizin; 1979 Oct; 18(4):204-8. PubMed ID: 530848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium coordination state as a factor of stability in 99mTc-complexes used in hepatobiliary system: comparative studies on 99mTc-complexes of pyridoxal with glutamate (Tc-PG) and isoleucine (Tc-PI).
    Horiuchi K; Yokoyama A; Tanaka H; Saji H; Odori T; Morita R; Torizuka K
    Eur J Nucl Med; 1981 Dec; 6(12):573-9. PubMed ID: 7333320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.